Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
view original post
Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.